Promoters continually post that Tilray sells cannabis in 20 countries.
I don't think that's true - Tilray's Manitoba Harvest sells hemp in a lot of countries maybe, but Tilray is not the global cannabis business they insist.
Anyway - seeing as how none of the promoters actually know what Tilrays international cannabis sales are - they reported $14.3 million in the last quarter reported.
So that's about it $56 million a year - TOTAL, all countries including Germany and Israel.
If we assume those two make up $10 million of the $14 million - and we then assume its $5 millon per quarter each- then doubling Tilrays European sales (which is basically Germany) is doubled - that means Tikray will report $40 million a year in medical cannabis once Hrrmany actually proceeds eventually.
$40 million a year in Europe, with Gross Profit of jus 35% means Tilray will report about $15 million BEFORE operating expense.
The country of Europe translates to about NOTHING worthwhile